Newly developed dual topoisomerase inhibitor P8-D6 is highly active in ovarian cancer
Background: Ovarian cancer (OvCa) constitutes a rare and highly aggressive malignancy and is one of the most lethal of all gynaecologic neoplasms. Due to chemotherapy resistance and treatment limitations because of side effects, OvCa is still not sufficiently treatable. Hence, new drugs for OvCa the...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
SAGE Publishing
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/8b89334405764c299bc1e0e335c0f7dc |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|